JenaValve

EuroIntervention

Volumn 8, Issue , 2012, Pages Q88-Q93

  Treede, Hendrik ^a   Rastan, Ardawan ^b   Ferrari, Markus ^c   Ensminger, Stephan ^d   Figulla, Hans Reiner ^c   Mohr, Friedrich Wilhelm ^b  

^a UNIVERSITY HEART CENTER HAMBURG   (Germany)

^b UNIVERSITY OF LEIPZIG HEART CENTER   (Germany)

^c University Heart Center Jena   (Germany)

^d UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; EUROPE; HUMAN; INFORMATION PROCESSING; MALE; MARKET; MULTICENTER STUDY; PROSPECTIVE STUDY; REGISTER; TRANSCATHETER AORTIC VALVE IMPLANTATION; AORTA VALVE STENOSIS; ARTICLE; BIOPROSTHESIS; EQUIPMENT; EVIDENCE BASED MEDICINE; HEART CATHETERIZATION; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; HEMODYNAMICS; METHODOLOGY; MORTALITY; PATHOPHYSIOLOGY; PATIENT SELECTION; PROSTHESIS; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME;

AORTIC VALVE STENOSIS; BIOPROSTHESIS; CARDIAC CATHETERIZATION; EVIDENCE-BASED MEDICINE; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HEMODYNAMICS; HUMANS; PATIENT SELECTION; PROSTHESIS DESIGN; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 84885421871     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV8SQA16     Document Type: Article

References (21)

1. Rodés-Cabau J, Webb JG, Cheung A, Ye J, Dumont E, Feindel CM, Osten M, Natarajan MK, Velianou JL, Martucci G, DeVarennes B, Chisholm R, Peterson MD, Lichtenstein SV, Nietlispach F, Doyle D, DeLarochellière R, Teoh K, Chu V, Dancea A, Lachapelle K, Cheema A, Latter D, Horlick E. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol. 2010;55:1091-2.
2. Thomas M, Schymik G, Walther T, Himbert D, Lefevre T, Treede H, Eggebrecht H, Rubino P, Michev I, Lange R, Anderson WN, Wendler O. Thirty-Day Results of the SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) Registry. A European Registry of Transcatheter Aortic Valve Implantation Using the Edwards SAPIEN Valve. Circulation. 2010;122:62-9.
3. Ye J, Cheung A, Lichtenstein SV, Nietlispach F, Albugami S, Masson JB, Thompson CR, Munt B, Moss R, Carere RG, Jamieson WR, Webb JG. Transapical transcatheter aortic valve implantation: follow-up to 3 years. J Thorac Cardiovasc Surg. 2010;139:1107-13.
4. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S; PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597-607.
5. Gilard M, Eltchaninoff H, Iung B, Donzeau-Gouge P, Chevreul K, Fajadet J, Leprince P, Leguerrier A, Lievre M, Prat A, Teiger E, Lefevre T, Himbert D, Tchetche D, Carrié D, Albat B, Cribier A, Rioufol G, Sudre A, Blanchard D, Collet F, Dos Santos P, Meneveau N, Tirouvanziam A, Caussin C, Guyon P, Boschat J, Le Breton H, Collart F, Houel R, Delpine S, Souteyrand G, Favereau X, Ohlmann P, Doisy V, Grollier G, Gommeaux A, Claudel JP, Bourlon F, Bertrand B, Van Belle E, Laskar M; FRANCE 2 Investigators. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med. 2012;366:1705-15.
6. Zahn R, Gerckens U, Grube E, Linke A, Sievert H, Eggebrecht H, Hambrecht R, Sack S, Hauptmann KE, Richardt G, Figulla HR, Senges J; German Transcatheter Aortic Valve Interventions-Registry Investigators. Eur Heart J. 2011;32:198-204.
7. Lauten A, Ferrari M, Petri A, Ensminger SM, Gummert JF, Boudjemline Y, Schubert H, Schumm J, Hekmat K, Schlosser M, Figulla HR. Experimental Evaluation of the JenaClip Transcatheter Aortic Valve. Cath Cardiovasc Interv. 2009;74:514-9.
8. Kempfert J, Rastan AJ, Mohr FW, Walther T. A new selfexpanding transcatheter aortic valve for transapical implantation-first in man implantation of the JenaValve?. Eur J Cardiothorac Surg. 2011;40:761-3.
9. Treede H, Mohr FW, Baldus S, Rastan A, Ensminger S, Arnold M, Kempfert J, Figulla HR. Transapical transcatheter aortic valve implantation using the JenaValve? system: acute and 30-day results of the multicentre CE-mark study. Eur J Cardiothorac Surg. 2012;41:e131-8.
10. Kodali SK, Williams MR, Smith CR, Svensson LG, Webb JG, Makkar RR, Fontana GP, Dewey TM, Thourani VH, Pichard AD, Fischbein M, Szeto WY, Lim S, Greason KL, Teirstein PS, Malaisrie SC, Douglas PS, Hahn RT, Whisenant B, Zajarias A, Wang D, Akin JJ, Anderson WN, Leon MB; PARTNER Trial Investigators. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012;366:1686-95.
11. Abdel-Wahab M, Zahn R, Horack M, Gerckens U, Schuler G, Sievert H, Eggebrecht H, Senges J, Richardt G; German transcatheter aortic valve interventions registry investigators. Aortic regurgitation after transcatheter aortic valve implantation: incidence and early outcome. Results from the German transcatheter aortic valve interventions registry. Heart. 2011;97:899-906.
12. Rajani R, Kakad M, Khawaja MZ, Lee L, James R, Saha M, Hildick-Smith D. Paravalvular regurgitation one year after transcatheter aortic valve implantation. Catheter Cardiovasc Interv. 2010;75:868-72.
13. Bauer F, Lemercier M, Zajarias A, Tron C, Eltchaninoff H, Cribier A. Immediate and long-term echocardiographic findings after transcatheter aortic valve implantation for the treatment of aortic stenosis: the Cribier-Edwards/Edwards-Sapien valve experience. J Am Soc Echocardiogr. 2010;23:370-6.
14. Dewey TM; PARTNER Trial Investigators. Transapical aortic valve replacement for critical aortic stenosis: results from the nonrandomized continued access cohort of the PARTNER trial. STS 2012, Fort Lauderdale, Jan 30, 2012.
15. Eggebrecht H, Schmermund A, Voigtländer T, Kahlert P, Erbel R, Mehta RH. Risk of stroke after transcatheter aortic valve implantation (TAVI): a meta-analysis of 10,037 published patients. EuroIntervention. 2012;8:129-38.
16. Valfrè C, Ius P, Minniti G, Salvador L, Bottio T, Cesari F, Rizzoli G, Gerosa G. The fate of Hancock II porcine valve recipients 25 years after implant. Eur J Cardiothorac Surg. 2010;38:141-6.
17. Mykén PS, Bech-Hansen O. A 20-year experience of 1712 patients with the Biocor porcine bioprosthesis. J Thorac Cardiovasc Surg. 2009;137:76-81.
18. Jamieson WR, Burr LH, Miyagishima RT, Germann E, Macnab JS, Stanford E, Chan F, Janusz MT, Ling H. Carpentier-Edwards supra-annular aortic porcine bioprosthesis: clinical performance over 20 years. J Thorac Cardiovasc Surg. 2005;130:994-1000.
19. Hadjinikolaou L, Boehm MC, Ganner C, Kendall SW, Rosin MD, Goldsmith IR, Spyt TJ. Aspire porcine bioprosthesis: ten years' experience. J Heart Valve Dis. 2005;14:47-53.
20. Kiefer P, Gruenwald F, Kempfert J, Aupperle H, Seeburger J, Mohr FW, Walther T. Crimping may affect the durability of transcatheter valves: an experimental analysis. Ann Thorac Surg. 2011;92:155-60.
21. Bates MG, Matthews IG, Fazal IA, Turley AJ. Postoperative permanent pacemaker implantation in patients undergoing transcatheter aortic valve implantation: what is the incidence and are there any predicting factors? Interact Cardiovasc Thorac Surg. 2011;12:243-53.